Novavax is down 3.2% while the rest of the market is up nicely.
as of this posting:
XBI is up 0.75%
NVAX is down 3.20%
And, the shorts are still deeply entrenched in Novavax, even with the HUGE erosion of the share price that we've already experienced.
My hope is the nanoflu trial does come through, in spite of Novavax management.
Then if the trial is a success, we'll see if Novavax management can navigate an FDA approval, marketing, etc.
My other hope is this downtrodden company is actually under accumulation while still beaten down, but will eventually the price will go higher before the trial results.
Right now, that does not appear to be too likely.